The essential anti-angiogenic strategies in cartilage engineering and osteoarthritic cartilage repair
Authors:
- 14 January 2022
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 79 (1) , 1-24
Abstract
In the cartilage matrix, complex interactions occur between angiogenic and anti-angiogenic components, growth factors, and environmental stressors to maintain a proper cartilage phenotype that allows for effective load bearing and force distribution. However, as seen in both degenerative disease and tissue engineering, cartilage can lose its vascular resistance. This vascularization then leads to matrix breakdown, chondrocyte apoptosis, and ossification. Research has shown that articular cartilage inflammation leads to compromised joint function and decreased clinical potential for regeneration. Unfortunately, few articles comprehensively summarize what we have learned from previous investigations. In this review, we summarize our current understanding of the factors that stabilize chondrocytes to prevent terminal differentiation and applications of these factors to rescue the cartilage phenotype during cartilage engineering and osteoarthritis treatment. Inhibiting vascularization will allow for enhanced phenotypic stability so that we are able to develop more stable implants for cartilage repair and regeneration.Keywords
Funding Information
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR067747)
This publication has 279 references indexed in Scilit:
- TNFSF15 Modulates Neovascularization and InflammationCancer Microenvironment, 2012
- The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signalingBone, 2011
- Chondrocyte innate immune myeloid differentiation factor 88–dependent signaling drives procatabolic effects of the endogenous toll‐like receptor 2/toll‐like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in miceArthritis & Rheumatism, 2010
- Osteochondral angiogenesis and increased protease inhibitor expression in OAOsteoarthritis and Cartilage, 2010
- Impairment of VEGF-A-stimulated lamellipodial extensions and motility of vascular endothelial cells by chondromodulin-I, a cartilage-derived angiogenesis inhibitorExperimental Cell Research, 2010
- Thrombospondins function as regulators of angiogenesisJournal of Cell Communication and Signaling, 2009
- Regulation of autophagy in human and murine cartilage: Hypoxia‐inducible factor 2 suppresses chondrocyte autophagyArthritis & Rheumatism, 2009
- Blocking vascular endothelial growth factor with soluble Flt‐1 improves the chondrogenic potential of mouse skeletal muscle–derived stem cellsArthritis & Rheumatism, 2008
- Spatiotemporal control over growth factor signaling for therapeutic neovascularization☆Advanced Drug Delivery Reviews, 2007
- The secretory leukocyte protease inhibitor (SLPI) suppresses cancer cell invasion but promotes blood‐borne metastasis via an invasion‐independent pathwayThe Journal of Pathology, 2007